Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126485631 | 12648563 | 1 | I | 20160801 | 20160812 | 20160812 | EXP | DE-TEVA-684207GER | TEVA | ZSCH?BITZ S, LASITSCHKA F, J?GER D, GR?LLICH C. ACTIVITY OF IMMUNE CHECKPOINT INHIBITION IN PLATINUM REFRACTORY GERM-CELL TUMORS. ANNALS OF ONCOLOGY. 2016; ARTICLE NUMBER MDW146 : 27(7):1356-1360 | 0.00 | M | Y | 0.00000 | 20160812 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126485631 | 12648563 | 1 | PS | OXALIPLATIN. | OXALIPLATIN | 1 | Unknown | Y | 22160 | ||||||||||
| 126485631 | 12648563 | 2 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Unknown | Y | 22160 | ||||||||||
| 126485631 | 12648563 | 3 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Unknown | Y | 22160 | ||||||||||
| 126485631 | 12648563 | 4 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Unknown | Y | 22160 | ||||||||||
| 126485631 | 12648563 | 5 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Unknown | Y | 77983 | ||||||||||
| 126485631 | 12648563 | 6 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Unknown | Y | 77983 | ||||||||||
| 126485631 | 12648563 | 7 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Unknown | Y | 77983 | ||||||||||
| 126485631 | 12648563 | 8 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Unknown | Y | 77983 | ||||||||||
| 126485631 | 12648563 | 9 | SS | PACLITAXEL. | PACLITAXEL | 1 | Unknown | Y | 75297 | ||||||||||
| 126485631 | 12648563 | 10 | SS | PACLITAXEL. | PACLITAXEL | 1 | Unknown | Y | 75297 | ||||||||||
| 126485631 | 12648563 | 11 | SS | PACLITAXEL. | PACLITAXEL | 1 | Unknown | Y | 75297 | ||||||||||
| 126485631 | 12648563 | 12 | SS | PACLITAXEL. | PACLITAXEL | 1 | Unknown | Y | 75297 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126485631 | 12648563 | 1 | Metastases to bone |
| 126485631 | 12648563 | 2 | Teratoma |
| 126485631 | 12648563 | 3 | Testicular yolk sac tumour |
| 126485631 | 12648563 | 4 | Metastases to liver |
| 126485631 | 12648563 | 5 | Metastases to bone |
| 126485631 | 12648563 | 6 | Metastases to liver |
| 126485631 | 12648563 | 7 | Teratoma |
| 126485631 | 12648563 | 8 | Testicular yolk sac tumour |
| 126485631 | 12648563 | 9 | Metastases to bone |
| 126485631 | 12648563 | 10 | Teratoma |
| 126485631 | 12648563 | 11 | Testicular yolk sac tumour |
| 126485631 | 12648563 | 12 | Metastases to liver |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126485631 | 12648563 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126485631 | 12648563 | Pancytopenia | Pancytopenia |
| 126485631 | 12648563 | Polyneuropathy | Polyneuropathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |